Figure 1 presents a side-by-side miRNA pathway–enrichment analysis of NurExone’s bone-marrow–derived extracellular vesicles versus a commercial reference. Therapeutic scores, weighted values that reflects the therapeutic potential of each miRNA by multiplying its expression level (in RPM) by a predefined weight based on its knownbiological function (e.g., neuroprotection, repair, or inflammation), were calculated for each category
Figure 1 presents a side-by-side miRNA pathway–enrichment analysis of NurExone’s bone-marrow–derived extracellular vesicles versus a commercial reference. Therapeutic scores, weighted values that reflects the therapeutic potential of each miRNA by multiplying its expression level (in RPM) by a predefined weight based on its knownbiological function (e.g., neuroprotection, repair, or inflammation), were calculated for each category